Skip to main content
Have a personal or library account? Click to login
Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution Cover

Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution

Open Access
|Dec 2010

References

  1. S. Ahmad and N. Dixit, Silymarin: a review of pharmacological aspects and bioavailability enhancement approach,(2007) 172-179; DOI: 10.4103/0253-7613.36534.
  2. S. Abrol, T. Aman and K. O. Parkash, Comparative study of different silymarin formulations: formulation, characterization and in vitro/in vivo evaluation,(2005) 45-51; DOI: 1567-2018/05 $50.00+.00.
  3. P. D. Nakhat, R. A. Naidu, I. B. Babla, S. Khan and P. G. Yeole, Design and evaluation of silymarin-HP-β-CD solid dispersion tablets,(2007) 287-289; DOI: 10.4103/0250-474X.33160.
  4. J. H. Hu and F. Q. Li, Improvement of the dissolution rate of silymarin by means of solid dispersions,(2004) 972-973; DOI: 10.1248/cpb.52.972.
  5. S. W. Jong, T. S. Kim, J. H. Park, and S. C. Chi, Formulation and biopharmaceutical evaluation of silymarin using SMEDDS,(2007) 82-89; DOI: 10.1007/BF02977782.
  6. W. Wachter and H. Zeskae, Flavanolignan Preparation and their Use for Preparation of Pharmaceuticals, U.S. Pat. 5,906,991, 25 May 1999.
  7. D. Voinovich, B. Perrisuiti and L. Maggaroto, Solid state mechanochemical simultaneous activation of the constituents of thephytochemical complex with crosslinked polymers,(2008) 1-14; DOI: 10.1002/jps.21417.
  8. J. B. Dressman and L. Christian, Improving drug solubility for oral delivery using solid dispersions,(2000) 47-60; DOI: 10.1016/S0939-6411(00)00076-X.
  9. Y. Rane, R. Mashru, M. Sankalia and J. Sankalia, Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology,(2007) Article 27; DOI: 10.1208/pt0802027.
  10. A. Avani and M. Renuka, Formulation development of taste-masked rapidly dissolving films of cetirizine hydrochloride,(2009) 48-56.
  11. S. J. Hwang, D. H. Won, M. S. Kim, S. Lee and J. S. Park, Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process,(2005) 199-208; DOI: 10.1016/j.ijpharm.2005.05.017.
  12. , USP Convention, Rockville 2000, p. 2235.
  13. P. Costa and L. J. Manuel Sousa, Modelling and comparison of dissolution profiles,(2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
  14. J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles,(1996) 64-74.
  15. R. P. Patel and M. M. Patel, Solid-state characterization and dissolution properties of lovastatin hydroxypropyl-beta-cyclodextrin inclusion complex,(2007) 72-81.
  16. S. Baboota, M. Dhalival and K. Kohli, Physicochemical characterization, in vitro dissolution behaviour, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds: preparation and properties of rofecoxib hydroxypropyl β-cyclodextrin inclusion complex: a technical note,(2005) 83-90; DOI: 10.1208/pt060114.
  17. M. A. Khan and A. A. Karnachi, Box-Behnken design for the optimization of formulation variables of indomethacin co-precipitates with polymer mixtures,(1996) 9-17; DOI: 10.1016/0378-5173(95)04216-4.
  18. S. Torrado, P. D. Torre and S. Torrado, Preparation, dissolution and characterization of pranziquantel solid dispersions,(1999) 1629-1633; DOI: 99A1042280.
  19. S. R. Vikram, M. R. Shelake, S. S. Shetty, A. B. Chavan-Patil, Y. V. Pore and S. G. Late, Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique,(2008) 1121-1129; DOI: 10.1211/jpp.60.9.0002.
  20. K. Okimoto, M. Miyake, R. Ibuki, M. Yasumura, N. Ohnishi and T. Nakai, Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose,(1997) 85-93; DOI: 10.1016/S0378-5173(97)00274-3.
  21. M. S. Nagarsenker and M. S. Joshi, Celecoxib cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage,(2005) 169-178; DOI: 10.1081/DDC-200047795.
DOI: https://doi.org/10.2478/v10007-010-0038-3 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian, Slovenian
Page range: 427 - 443
Published on: Dec 17, 2010
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2010 Dalwadi Sonali, Soni Tejal, Thakkar Vaishali, Gandhi Tejal, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.